Category: Oncology/Hematology
Global Oncology/Hematology
-
Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Global Forecast 2024-2030
... and expected to reach USD 78.60 billion in 2024, at a CAGR 12.89% to reach USD 163.28 billion by 2030. Global Cancer Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Immune Checkpoint Inhibitors for Lung Cancer Market by Products (Atezolizumab, Durvalumab, Nivolumab), Type (CTLA-4 Inhibitors, PD-1 Inhibitors, PD-L1 Inhibitors), End-Users - Global Forecast 2024-2030
... at USD 1.01 billion in 2023 and expected to reach USD 1.15 billion in 2024, at a CAGR 14.55% to reach USD 2.62 billion by 2030. Global Immune Checkpoint Inhibitors for Lung Cancer Market FPNV ... Read More
-
Nanobiotechnology Market by Product (Nano-Enabled Drugs, Nanodevices, Nanoparticles), Application (Agriculture, Cancer Treatment, Diagnostics) - Global Forecast 2024-2030
... billion in 2024, at a CAGR 16.04% to reach USD 9.91 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Nanobiotechnology Market. It offers a comprehensive assessment of vendors, ... Read More
-
Breast Cancer Liquid Biopsy Testing Devices Market by Offerings (Assay & Reagents Kits, Instruments), Circulating Biomarker (Circulating Tumar DNA, Circulating Tumor Cell, Extracellular Vesicles), End-User, Appplication - Global Forecast 2024-2030
... Testing Devices Market size was estimated at USD 858.76 million in 2023 and expected to reach USD 1,023.60 million in 2024, at a CAGR 19.59% to reach USD 3,004.57 million by 2030. Global Breast Cancer ... Read More
-
Oncology Biosimilars Market by Application (Cancer Treatment Drugs, Supportive Care Drugs), End-User (Hospitals, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 5.48 billion in 2024, at a CAGR 18.11% to reach USD 14.91 billion by 2030. Global Oncology Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Oncology Biosimilars ... Read More
-
Oncology Based In-Vivo CRO Market by Services (Biomarker Development, Clinical Trial Management, Pharmacokinetics Studies), Indication (Hematological Malignancies, Rare Cancer, Solid Tumor), End-User - Global Forecast 2024-2030
... at USD 1.27 billion in 2023 and expected to reach USD 1.41 billion in 2024, at a CAGR 11.34% to reach USD 2.70 billion by 2030. Global Oncology Based In-Vivo CRO Market FPNV Positioning Matrix ... Read More
-
Prostate Cancer Therapeutics Market by Drug Class (Chemotherapy, Hormonal Therapy, Immunotherapy), Distribution Channel (Drug Stores & Retail Pharmacies, Hospitals Pharmacies, Online Pharmacies) - Global Forecast 2024-2030
... USD 10.00 billion in 2023 and expected to reach USD 10.62 billion in 2024, at a CAGR 6.32% to reach USD 15.36 billion by 2030. Global Prostate Cancer Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Hematological Malignancies Market by Types (Leukemia, Lymphoma, Multiple Myeloma), Treatment (Bone Marrow Transplantation, Chemotherapy, Chimeric Antigen Receptor (Car) T Cell Therapy), Diagnosis, End-Users - Global Forecast 2024-2030
... USD 15.33 billion in 2023 and expected to reach USD 16.84 billion in 2024, at a CAGR 9.92% to reach USD 29.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Acute Lymphoblastic Leukemia Treatment Market (ALL) by Types of Cell (B-cell ALL, Philadelphia chromosome: Positive (Ph+) and negative (Ph-), T-cell ALL), Therapy (Chemotherapy, Radiation Therapy, Stem Cell Transplantation), End-User - Global Forecast 202
... Lymphoblastic Leukemia Treatment Market size was estimated at USD 3.22 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 6.45% to reach USD 4.99 billion by 2030. FPNV Positioning ... Read More
-
Antibody Drug Conjugates Contract Manufacturing Market by Linker (Cleavable, Non-cleavable), Condition (Breast Cancer, Lymphoma, Myeloma), End Use - Global Forecast 2024-2030
... in 2023 and expected to reach USD 13.06 billion in 2024, at a CAGR 11.82% to reach USD 25.99 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antibody ... Read More
-
In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030. Global In Silico Clinical Trials Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Global Forecast 2024-2030
... 209.37 billion in 2023 and expected to reach USD 231.55 billion in 2024, at a CAGR 9.30% to reach USD 390.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Global Forecast 2024-2030
... and expected to reach USD 17.62 billion in 2024, at a CAGR 8.74% to reach USD 29.26 billion by 2030. Global Bone Marrow Transplantation Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2024-2030
... in 2023 and expected to reach USD 8.42 billion in 2024, at a CAGR 7.40% to reach USD 12.83 billion by 2030. Global Skin Cancer Dermatology Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
... at USD 7.34 billion in 2023 and expected to reach USD 7.67 billion in 2024, at a CAGR 9.10% to reach USD 13.51 billion by 2030. Global Oncology Precision Medicine Market FPNV Positioning Matrix The ... Read More
-
Transcatheter Devices Market by Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Repair Devices, Transcatheter Replacement Devices), Application (Cardiovascular, Neurology, Oncology) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 15.97 billion in 2024, at a CAGR 13.70% to reach USD 34.56 billion by 2030. Global Transcatheter Devices Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030
... Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030. FPNV Positioning Matrix ... Read More
-
Cancer Biological Therapy Market by Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), Route of Administration (Intramuscular, Intravenous, Subcutaneous), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 72.42 billion in 2024, at a CAGR 11.60% to reach USD 140.04 billion by 2030. Global Cancer Biological Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030
... at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024, at a CAGR 25.34% to reach USD 54.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection) - Global Forecast 2024-2030
... 2023 and expected to reach USD 414.56 million in 2024, at a CAGR 21.42% to reach USD 1,332.43 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the EV-Based Liquid ... Read More
-
Erythropoietin Stimulating Agents Market by Type (Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta), Application (Anemia, Antiretroviral Treatment, Cancer Chemotherapy) - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.32 billion in 2024, at a CAGR 5.64% to reach USD 14.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Erythropoietin Stimulating ... Read More
-
Flow Cytometry in Oncology & Immunology Market by Type (Immunology, Oncology), Technology (Bead-based Flow Cytometry, Cell-based Flow Cytometry), Product & Service, End User - Global Forecast 2024-2030
... size was estimated at USD 1.10 billion in 2023 and expected to reach USD 1.18 billion in 2024, at a CAGR 9.33% to reach USD 2.06 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2024-2030
... Discovery Outsourcing Market size was estimated at USD 1.60 billion in 2023 and expected to reach USD 1.84 billion in 2024, at a CAGR 15.59% to reach USD 4.41 billion by 2030. Global Cancer Immunotherapy ... Read More
-
Women’s Health Diagnostics Market by Type (Point-of-Care, Self Check), Application (Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.82 billion in 2024, at a CAGR 9.25% to reach USD 80.59 billion by 2030. Global Women’s Health Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
Research Assistance
